SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 10/25/12 OncoMed Pharmaceuticals Inc S-1/A 6:3.0M RR Donnelley/FA |
Document/Exhibit Description Pages Size 1: S-1/A Amendment No. 4 to Registration Statement on Form HTML 1.91M S-1 2: EX-10.1(C) Second Amendment Regarding Payment of Certain HTML 16K Milestone Payments 3: EX-10.2(B) Amendment 1 to the Collaboration and Option HTML 31K Agreement 4: EX-10.20 Collaboration Agreement HTML 74K 5: EX-10.21 Multi-Product License Agreement HTML 131K 6: EX-23.1 Consent of Independent Registered Public HTML 6K Accounting Firm
Consent of independent registered public accounting firm |
Exhibit 23.1
Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated May 11, 2012, in Amendment No. 4 to the Registration Statement (Form S-1 No. 333-181331) and related Prospectus of OncoMed Pharmaceuticals, Inc. for the registration of shares of its common stock.
Redwood City, California
This ‘S-1/A’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed as of: | 10/25/12 | |||
Filed on: | 10/24/12 | |||
5/11/12 | S-1 | |||
List all Filings |